Skip Navigation


Rheumatology Advance Access originally published online on May 18, 2005
Rheumatology 2005 44(9):1115-1121; doi:10.1093/rheumatology/keh689
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/9/1115    most recent
keh689v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oen, K.
Right arrow Articles by Reed, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oen, K.
Right arrow Articles by Reed, M.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis

K. Oen, P. N. Malleson3, D. A. Cabral3, A. M. Rosenberg4, R. E. Petty3, P. Nickerson1,5 and M. Reed2

Departments of Paediatrics, 1 Internal Medicine and 2 Radiology, University of Manitoba, Winnipeg, Manitoba, 3 Department of Paediatrics, University of British Columbia, Vancouver, British Columbia, 4 Department of Paediatrics, University of Saskatchewan, Saskatoon, Saskatchewan and 5 Canadian Blood Transfusion Service, Winnipeg, Manitoba, Canada.

Correspondence to: K. Oen, Arthritis Centre, Health Sciences Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: koen{at}exchange.hsc.mb.ca.

Objectives. Single nucleotide polymorphisms (SNPs) in cytokine genes have been associated with risk of a number of autoimmune diseases. Moreover, some SNPs are associated with variations in rates of in vitro gene expression, and it is therefore possible that these functional polymorphisms may differentially affect inflammatory processes and disease outcome. This project's objective was to determine whether cytokine genotypes correlate with disease outcomes in patients with juvenile rheumatoid arthritis (JRA).

Methods. Genotypes of SNPs of pro-inflammatory cytokines, tumour necrosis factor-{alpha} –308G ->A, interleukin-6 (IL-6) –174G ->C and interferon-gamma +874G ->A, and anti-inflammatory, immunosuppressive cytokines, interleukin-10 –1082G ->A, –819C ->T and –592A ->C and transforming growth factor-ß1 (TGF-ß1) codon 10T ->C and codon 25G ->C, were determined for patients with JRA who previously participated in a long-term outcome study. Cytokine genotypes and clinical variables showing significant correlations with clinical outcomes at the {alpha} = 0.100 level in univariate analyses were entered in multivariate tests.

Results. In multivariate tests, the IL-6 genotype –174G/G was positively correlated with pain [regression coefficient B = 0.899, 95% confidence intervals (CI) 0.185, 1.612, P = 0.014]. The homozygous TGF-ß1 codon 25G/G genotype showed a protective effect against joint space narrowing on radiographs taken within 2 yr of disease onset, but confidence intervals were wide [odds ratio (OR) 0.176, 95% CI 0.037, 0.837 P = 0.029].

Conclusions. The correlation of IL-6 genotype with pain and the possible association of the TGF-ß1 codon 25 genotype with short-term radiographic damage (G/C with greater risk and G/G with decreased risk) suggests that both these polymorphisms may be useful early prognostic indicators. Further studies of the relation between cytokine genotypes and outcomes in patients with all forms of juvenile idiopathic arthritis (JIA) are warranted.

KEY WORDS: Juvenile idiopathic arthritis, Juvenile rheumatoid arthritis, Cytokine genes, Long-term outcomes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
R. Cimaz, M.-A. Cazalis, C. Reynaud, V. Gerloni, F. Zulian, M. Biggioggero, G. Martini, I. Pontikaki, F. Fantini, B. Mougin, et al.
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors
Ann Rheum Dis, July 1, 2007; 66(7): 900 - 904.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. J. Peake, K. Khawaja, A. Myers, M. A. Nowell, S. A. Jones, A. D. Rowan, T. E. Cawston, and H. E. Foster
Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor
Rheumatology, December 1, 2006; 45(12): 1485 - 1489.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.